B-cell Lymphoma
Showing 51 - 75 of 95
B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose
Completed
- B-cell Lymphoma
- +2 more
- BI-1206 single agent dose escalation phase
- +3 more
-
Leicester, England, United Kingdom
- +4 more
Jun 17, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,
Recruiting
- Acute Myelogenous Leukemia
- +17 more
- Allopurinol
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
May 21, 2021
B-cell Lymphoma Trial (Fast Dual CAR-T Injection)
Not yet recruiting
- B-cell Lymphoma
- Fast Dual CAR-T Injection
- (no location specified)
May 7, 2021
Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (hCD19.IL15.CAR-iNKT)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
-
Xuzhou, Jiangsu, ChinaThe Affiliated hospital of Xuzhou medical University
Mar 24, 2021
B-Cell Lymphoma Trial in Beijing (GB241, Rituximab)
Completed
- B-Cell Lymphoma
- GB241
- Rituximab
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 19, 2021
Acute Lymphoblastic Leukemia, Chronic Lymphoblastic Leukemia, B-cell Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide +
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
-
Wuhan, Hubei, China
- +1 more
Mar 11, 2021
Chronic Lymphocytic Leukemia, B-Cell Lymphoma Trial in United States (DTRMWXHS-12, DTRM-505, DTRM-555)
Completed
- Chronic Lymphocytic Leukemia
- B-Cell Lymphoma
- DTRMWXHS-12
- +2 more
-
Phoenix, Arizona
- +5 more
Nov 24, 2020
B-cell Malignancy, B-cell Lymphoma, B-Cell Acute Lymphoblastic Leukaemia Trial in Shanghai (CD19 CAR T)
Recruiting
- B-cell Malignancy
- +2 more
- CD19 CAR T
-
Shanghai, ChinaShanghai Tong Ren hospital
Nov 3, 2020
T-Cell Lymphoma, B-Cell Lymphoma Trial in Worldwide (enzastaurin)
Completed
- T-Cell Lymphoma
- B-Cell Lymphoma
-
Anaheim, California
- +13 more
Sep 23, 2020
B-cell Lymphoma Trial in United States (SD-101, Radiation therapy)
Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)
Completed
- Lymphoma
- B-cell Lymphoma
- Leukapheresis
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
B-cell Lymphoma Trial in Essen (Lenalidomide)
Completed
- B-cell Lymphoma
-
Essen, GermanyKlinik für Hämatologie, Universitätsklinikum Essen
Feb 25, 2020
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in ChongQing (anti-CD19 UCAR-T cells, Fludarabine, Cytoxan)
Unknown status
- B-cell Acute Lymphoblastic Leukemia
- B-cell Lymphoma
- anti-CD19 UCAR-T cells
- +3 more
-
ChongQing, Chongqing, ChinaDepartment of Hematology, Xinqiao Hospital
Feb 7, 2020
Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States
Completed
- Relapsed or Refractory Lymphoproliferative Malignancies
- +4 more
- Pralatrexate Injection
- +3 more
-
Los Angeles, California
- +14 more
Dec 27, 2019
Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)
Completed
- Marginal Zone Lymphoma
- B-cell Lymphoma
-
Tucson, Arizona
- +24 more
Oct 8, 2019
Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)
Completed
- Follicular Lymphoma
- +2 more
-
Burbank, California
- +11 more
Mar 26, 2019
B-cell Lymphoma Trial in Belgium, France (Ibrutinib and immunochemotherapies)
Terminated
- B-cell Lymphoma
- Ibrutinib and immunochemotherapies
-
Bruxelles, Belgium
- +14 more
Oct 9, 2018
Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma Trial in Baltimore (drug, radiation, biological)
Terminated
- Lymphoma
- +3 more
- Fludarabine
- +6 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 26, 2018
Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive
Unknown status
- B-cell Lymphoma
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 15, 2018